Compile Data Set for Download or QSAR
maximum 50k data
Found 26 Enz. Inhib. hit(s) with all data for entry = 50030778
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301249(4-(2-(dimethylamino)acetamido)-N-(4-(2-(2-hydroxy-...)
Affinity DataEC50:  0.5nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301256(CHEMBL570834 | N-(4-(2-(2-hydroxy-2-(5-hydroxy-3-o...)
Affinity DataEC50:  5.70nMAssay Description:Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301256(CHEMBL570834 | N-(4-(2-(2-hydroxy-2-(5-hydroxy-3-o...)
Affinity DataEC50:  1.20nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301247(2-(4-(4-(2-(2-hydroxy-2-(6-hydroxy-3-oxo-3,4-dihyd...)
Affinity DataEC50:  12nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301246(4-guanidino-N-(4-(2-(2-hydroxy-2-(6-hydroxy-3-oxo-...)
Affinity DataEC50:  4.10nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301248(4-amino-N-(4-(2-(2-hydroxy-2-(6-hydroxy-3-oxo-3,4-...)
Affinity DataEC50:  9nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301255(2-(4-(4-(2-(2-hydroxy-2-(5-hydroxy-3-oxo-3,4-dihyd...)
Affinity DataEC50:  1nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50151720(ARFORMOTEROL TARTRATE | CHEMBL1363 | CHEMBL605993 ...)
Affinity DataEC50:  0.400nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301245(2,5-diamino-N-(4-(4-(2-(2-hydroxy-2-(5-hydroxy-3-o...)
Affinity DataEC50:  5.40nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301250(3-(4-(4-(2-(2-hydroxy-2-(5-hydroxy-3-oxo-3,4-dihyd...)
Affinity DataEC50:  1.80nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301252(4-amino-N-(4-(2-(2-hydroxy-2-(5-hydroxy-3-oxo-3,4-...)
Affinity DataEC50:  1.10nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301254(4-(2-aminoacetamido)-N-(4-(2-(2-hydroxy-2-(5-hydro...)
Affinity DataEC50:  1.20nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301253(4-guanidino-N-(4-(2-(2-hydroxy-2-(5-hydroxy-3-oxo-...)
Affinity DataEC50:  1nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50151720(ARFORMOTEROL TARTRATE | CHEMBL1363 | CHEMBL605993 ...)
Affinity DataEC50:  86nMAssay Description:Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301245(2,5-diamino-N-(4-(4-(2-(2-hydroxy-2-(5-hydroxy-3-o...)
Affinity DataEC50:  24nMAssay Description:Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301246(4-guanidino-N-(4-(2-(2-hydroxy-2-(6-hydroxy-3-oxo-...)
Affinity DataEC50:  18nMAssay Description:Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301247(2-(4-(4-(2-(2-hydroxy-2-(6-hydroxy-3-oxo-3,4-dihyd...)
Affinity DataEC50:  28nMAssay Description:Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301248(4-amino-N-(4-(2-(2-hydroxy-2-(6-hydroxy-3-oxo-3,4-...)
Affinity DataEC50:  11nMAssay Description:Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301249(4-(2-(dimethylamino)acetamido)-N-(4-(2-(2-hydroxy-...)
Affinity DataEC50:  5.30nMAssay Description:Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301250(3-(4-(4-(2-(2-hydroxy-2-(5-hydroxy-3-oxo-3,4-dihyd...)
Affinity DataEC50:  9.90nMAssay Description:Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301251(4-(3-aminopropanamido)-N-(4-(2-(2-hydroxy-2-(5-hyd...)
Affinity DataEC50:  4.60nMAssay Description:Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301252(4-amino-N-(4-(2-(2-hydroxy-2-(5-hydroxy-3-oxo-3,4-...)
Affinity DataEC50:  3.40nMAssay Description:Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301253(4-guanidino-N-(4-(2-(2-hydroxy-2-(5-hydroxy-3-oxo-...)
Affinity DataEC50:  1.80nMAssay Description:Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301255(2-(4-(4-(2-(2-hydroxy-2-(5-hydroxy-3-oxo-3,4-dihyd...)
Affinity DataEC50:  3.5nMAssay Description:Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301254(4-(2-aminoacetamido)-N-(4-(2-(2-hydroxy-2-(5-hydro...)
Affinity DataEC50:  4.5nMAssay Description:Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Boehringer Ingelheim Pharma

Curated by ChEMBL
LigandPNGBDBM50301251(4-(3-aminopropanamido)-N-(4-(2-(2-hydroxy-2-(5-hyd...)
Affinity DataEC50:  0.900nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed